safinamide has been researched along with harmaline in 1 studies
Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) | Studies (harmaline) | Trials (harmaline) | Recent Studies (post-2010) (harmaline) |
---|---|---|---|---|---|
199 | 29 | 159 | 633 | 2 | 125 |
Protein | Taxonomy | safinamide (IC50) | harmaline (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 4.9 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.012 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.0329 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abarbri, M; El Qami, A; Frlan, R; Gobec, S; Jismy, B; Knez, D; Kos, J; Pišlar, A | 1 |
1 other study(ies) available for safinamide and harmaline
Article | Year |
---|---|
Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
Topics: Antiparkinson Agents; Bromides; Coordination Complexes; Humans; Indazoles; Metals; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Protein Binding; Small Molecule Libraries; Structure-Activity Relationship; Tyramine | 2021 |